Executive interview – InflaRx

Executive interview – InflaRx

CEO and founder, Niels Riedemann, discusses InflaRx’s core technology including its lead product, IFX-1. He also highlights the advantages of the company’s acute and chronic inflammation products versus the current standard of care and the competition. Finally, he provides an update on InflaRx’s expected near-term news flow.


You may also be interested in these:

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free